These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36336528)

  • 1. Predictors of herpes zoster vaccination among Australian adults aged 65 and over.
    Ricks T; Trent MJ; MacIntyre CR
    Vaccine; 2022 Nov; 40(50):7182-7186. PubMed ID: 36336528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community.
    Benedict Kpozehouen E; Raina Macintyre C; Tan TC
    Vaccine; 2024 Sep; 42(22):126003. PubMed ID: 38789372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
    Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
    Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece.
    Tsiligianni I; Bouloukaki I; Papazisis G; Paganas A; Chatzimanolis E; Kalatharas M; Platakis I; Tirodimos I; Dardavesis T; Tsimtsiou Z
    Public Health; 2023 Nov; 224():195-202. PubMed ID: 37820537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
    Nicholls LAB; Gallant AJ; Cogan N; Rasmussen S; Young D; Williams L
    Vaccine; 2021 Jun; 39(26):3520-3527. PubMed ID: 34023136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of influenza, pneumococcal and herpes zoster vaccination coverage in Australian aged care residents, 2018 to 2022.
    Bennett N; Morris B; Malloy MJ; Lim LL; Watson E; Bull A; Sluggett J; Worth LJ;
    Infect Dis Health; 2023 Nov; 28(4):253-258. PubMed ID: 37147271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis.
    Wang Q; Yang L; Li L; Liu C; Jin H; Lin L
    JMIR Public Health Surveill; 2023 Mar; 9():e43893. PubMed ID: 36892937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Benedict Kpozehouen E; Macintyre CR; Tan TC
    Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster (HZ) vaccine coverage and confidence in Italy: a Nationwide cross-sectional study, the OBVIOUS project.
    Salussolia A; Capodici A; Scognamiglio F; La Fauci G; Soldà G; Montalti M; Di Valerio Z; Fantini MP; Odone A; Costantino C; Larson HJ; Leask J; Lenzi J; Gori D;
    BMC Infect Dis; 2024 Apr; 24(1):438. PubMed ID: 38658871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
    Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
    Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to receive Herpes Zoster vaccination among adults and older people: A cross sectional study in Italy.
    Di Giuseppe G; Pelullo CP; Napoli A; Napolitano F
    Vaccine; 2023 Nov; 41(48):7244-7249. PubMed ID: 37880069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
    Litt J; Booy R; Bourke D; Dwyer DE; Leeb A; McCloud P; Stein AN; Woodward M; Cunningham AL
    Hum Vaccin Immunother; 2020 Dec; 16(12):3081-3089. PubMed ID: 32420793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
    Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
    JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
    Parikh R; Widenmaier R; Lecrenier N
    Expert Rev Vaccines; 2021 Sep; 20(9):1065-1075. PubMed ID: 34311643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
    Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
    Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes Zoster Vaccine Coverage in Older Adults in the U.S., 2007-2013.
    Zhang D; Johnson K; Newransky C; Acosta CJ
    Am J Prev Med; 2017 Jan; 52(1):e17-e23. PubMed ID: 28340974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
    Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
    J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.